BIPSX Fees and Costs — Biotechnology UltraSector ProFund, Service Class
Data updated: 2026-10-13
The net expense ratio is 2.52%: a 0.75% management fee, a 1.00% 12b-1 fee plus 0.77% other expenses. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $29K in broker commissions, 0.0221% of average net assets, and portfolio turnover was 52%.
BIPSX Fees and Expenses
Annual operating expenses and sales charges of BIPSX. Prospectus, as of July 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.75% |
| 12b-1 fee | 1.00% |
| Other expenses | 0.77% |
| Gross expense ratio | 2.52% |
| Fee waiver | — |
| Net expense ratio | 2.52% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
BIPSX Costs Over Time
On $10,000 invested in BIPSX, assuming 5% a year before costs, total costs come to $1,542 over 5 years, cutting the return by 2.67% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 2.52%) | $265 | $812 | $1,386 |
| Trading costs (broker commissions) | $2 | $7 | $12 |
| Lost growth on money paid in costs | $0 | $41 | $144 |
| Total costs | $267 | $861 | $1,542 |
| Value after costs | $10,233 | $10,716 | $11,221 |
| Impact on return, per year | 2.67% | 2.67% | 2.67% |
BIPSX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending July 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0221%
- Total broker commissions: $29K
- Bought from dealers (principal trades, not a cost): $7.6B
- Portfolio turnover (prospectus): 52%
BIPSX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Susquehanna Securities | $17K | 59.58% |
| BNP Paribas Securities Corp. | $12K | 40.42% |
BIPSX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| SG Americas Securities, LLC | $2.0B | 26.72% |
| HSBC Securities (USA) Inc. | $1.8B | 23.90% |
| Natwest Markets Securities Inc. | $1.5B | 19.41% |
| CF SECURED HOLDINGS, LLC | $773.2M | 10.15% |
| RBC Capital Markets, LLC | $718.3M | 9.43% |
| UMB Financial Services, Inc. | $651.1M | 8.55% |
| Credit Agricole Securities (USA) Inc. | $138.6M | 1.82% |
Biotechnology UltraSector ProFund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| BIPIX | Investor Class | 1.52% | — |
| BIPSX | Service Class | 2.52% | — |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.